[1] Anghel D, Anghel R, Corciova F, et al. Preoperative arrhythmias such as atrial fibrillation: cardiovascular surgery risk factor[J]. Biomed Res Int, 2014, 2014:584918.
[2] Badhwar V, Rankin JS, Damiano RJJr, et al. The society of thoracic surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation[J]. Ann Thorac Surg, 2017, 103(1):329-341.
[3] Alb?ge A, Johansson B, Kenneb?ck G, et al. Long-term follow-up of cardiac rhythm in 320 patients after the Cox-maze Ⅲprocedure for atrial fibrillation[J]. Ann Thorac Surg, 2016, 101(4):1443-1449.
[4] Garcia-Villarreal OA, Fernández-Cese?a E, Vega-Hernández R. Cox maze Ⅲ procedure: the best alternative in surgery for atrial fibrillation[J]. J Thorac Cardiovasc Surg, 2014, 148(1):368-369.
[5] Stulak JM, Suri RM, Burkhart HM, et al. Surgical ablation for atrial fibrillation for two decades: are the results of new techniques equivalent to the Cox maze Ⅲ procedure?[J]. J Thorac Cardiovasc Surg, 2014, 147(5):1478-1486.
[6] Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4):c179-c184.
[7] 王常田, 张雷, 秦涛, 等. 改良Cox迷宫Ⅲ治疗瓣膜病合并房颤的安全性及疗效分析[J]. 医学研究生学报, 2021, 34(4):394-398.
[8] Massoth C, Zarbock A, Meersch M. Acute kidney injury in cardiac surgery[J]. Crit Care Clin, 2021, 37(2):267-278.
[9] 后青, 陆凤霞, 姚昊, 等. 心脏及血管手术后急性肾损伤的危险因素分析[J]. 临床肾脏病杂志, 2022, 22(1):5-9.
[10] O'Neal JB, Shaw AD, Billings FT 4th. Acute kidney injury following cardiac surgery: current understanding and future directions[J]. Crit Care, 2016, 20(1):187.
[11] Hong HJ, Lee Y, Kim SH, et al. Incidence and risk factors of acute kidney injury after maze operation in patients with rheumatic mitral valve disease[J]. J Thorac Dis, 2022, 14(9):3408-3414.
[12] Bakir NH, Khiabani AJ, MacGregor RM, et al. Concomitant surgical ablation for atrial fibrillation is associated with increased risk of acute kidney injury but improved late survival[J]. J Thorac Cardiovasc Surg, 2022, 164(6):1847-1857.e3.
[13] 陈莉明, 陈伟, 陈燕燕, 等. 成人围手术期血糖监测专家共识[J]. 中国糖尿病杂志, 2021, 29(2):81-85.
[14] Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control[J]. Endocr Pract, 2009, 15(4):353-369.
[15] 桑文涛, 杨可慧, 李笑, 等. 造影剂肾病早期预防的研究进展[J].中华危重病急救医学,2019,31(9):1174-1178.
[16] Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines[J]. Eur Radiol, 2011, 21(12):2527-2541.
[17] McCallum W, Testani JM. Updates in cardiorenal syndrome[J]. Med Clin North Am, 2023, 107(4):763-780.
[18] 曾晓东, 雷黎明, 熊卫萍, 等. 输血与心脏移植术后急性肾损伤相关性研究[J]. 中国胸心血管外科临床杂志, 2020, 27(4):426-430.
[19] Rasmussen SR, Kandler K, Nielsen RV, et al. Association between transfusion of blood products and acute kidney injury following cardiac surgery[J]. Acta Anaesthesiol Scand, 2020, 64(10):1397-1404.
[20] Parreiras VC, Rocha Ide S, Martins AS, et al. Influence of fresh frozen plasma as a trigger factor for kidney dysfunction in cardiovascular surgery[J]. Rev Bras Cir Cardiovasc, 2012, 27(3):405-410.
[21] Kindzelski BA, Corcoran P, Siegenthaler MP, et al. Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery[J]. Perfusion, 2018, 33(1):62-70.
[22] Okorie ON, Dellinger P. Lactate: biomarker and potential therapeutic target[J]. Crit Care Clin, 2011, 27(2):299-326.
[23] Kogan A, Preisman S, Bar A, et al. The impact of hyperlactatemia on postoperative outcome after adult cardiac surgery[J]. J Anesth, 2012, 26(2):174-178.
[24] Radovic M, Bojic S, Kotur-Stevuljevic J, et al. Serum lactate as reliable biomarker of acute kidney injury in low-risk cardiac surgery patients[J]. J Med Biochem, 2019, 38(2):118-125.